Welford, R., Mühleman, A., Priestman, D., Garzotti, M., Deymier, C., Ertel, E., . . . Probst, M. (2017). Lucerastat, an iminosugar for substrate reduction therapy in Fabry Disease: Preclinical evidence. Karger.
芝加哥风格引文Welford, R., et al. Lucerastat, an Iminosugar for Substrate Reduction Therapy in Fabry Disease: Preclinical Evidence. Karger, 2017.
MLA引文Welford, R., et al. Lucerastat, an Iminosugar for Substrate Reduction Therapy in Fabry Disease: Preclinical Evidence. Karger, 2017.
警告：这些引文格式不一定是100％准确.